Scientists in Canada are currently recruiting participants for a clinical trial to determine the efficacy of microneedling as a treatment option on people with genetic hair loss.
An emerging option as a treatment for a number of skin-related issues, microneedling is based around the theory that skin, when finely-pricked, responds in certain ways that can be beneficial. In cosmetic surgery microneedling is used to create puncture channels which the body fills will collagen and elastin, thereby allegedly improving skin texture and firmness.
Male Pattern Baldness will affect most men
The clinical trial in Canada aims to ascertain how effective it is helping to regenerate hair lost to Male Pattern Baldness, the most common form of hair loss which will affect most men by retirement age.
The trials will take place at the Vancouver Skin Care Centre in British Columbia, whose research team explains that “microneedling has been shown to overexpress hair growth factors which may enhance or stimulate miniaturised hairs to grow. It has also been shown to increase the absorption of topical products significantly.”
In their study, the team will be using topical 5% Minoxidil on each participant throughout “as this will prolong the effects of regrowth.”
A total of 20 people are being sought for the trial, with eligibility limited to males between 18 and 65 whose hair loss is between IIIa and IV on the Norwood scale. Microneedling will be applied to just half of each patient’s head, so that hair calibre diameter and hair counts can be measured and compared.
While the team do not specify the exact method they intend to use for the microneedling treatment, they do state that “the area will be rolled with microneedles”, which suggests a derma roller, a hand-held device with a spiked wheel which is rolled across the skin.
Other options for hair loss
Belgravia is not aware of any clinical data to support derma rollers’ efficacy in relation to being used in conjunction with minoxidil, which is why we do not recommend them to clients at present.
The male hair loss treatment options that are currently available are typically based around clinically-proven medical treatments which are MHRA licensed and FDA approved.
Additional hair growth supporting products can also be used to supplement this pharmaceutical approach. These include the HairMax LaserComb, which was the first LLLT device to be FDA-cleared to promote hair growth and treat hair loss, and a range of other options which can be discussed and recommended, based on your requirements and suitability, following a consultation with a hair loss specialist.
The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.